Literature DB >> 22556262

Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.

Masashi Takawa1, Hyun-Soo Cho, Shinya Hayami, Gouji Toyokawa, Masaharu Kogure, Yuka Yamane, Yukiko Iwai, Kazuhiro Maejima, Koji Ueda, Akiko Masuda, Naoshi Dohmae, Helen I Field, Tatsuhiko Tsunoda, Takaaki Kobayashi, Takayuki Akasu, Masanori Sugiyama, Shin-ichi Ohnuma, Yutaka Atomi, Bruce A J Ponder, Yusuke Nakamura, Ryuji Hamamoto.   

Abstract

Although the physiologic significance of lysine methylation of histones is well known, whether lysine methylation plays a role in the regulation of nonhistone proteins has not yet been examined. The histone lysine methyltransferase SETD8 is overexpressed in various types of cancer and seems to play a crucial role in S-phase progression. Here, we show that SETD8 regulates the function of proliferating cell nuclear antigen (PCNA) protein through lysine methylation. We found that SETD8 methylated PCNA on lysine 248, and either depletion of SETD8 or substitution of lysine 248 destabilized PCNA expression. Mechanistically, lysine methylation significantly enhanced the interaction between PCNA and the flap endonuclease FEN1. Loss of PCNA methylation retarded the maturation of Okazaki fragments, slowed DNA replication, and induced DNA damage, and cells expressing a methylation-inactive PCNA mutant were more susceptible to DNA damage. An increase of methylated PCNA was found in cancer cells, and the expression levels of SETD8 and PCNA were correlated in cancer tissue samples. Together, our findings reveal a function for lysine methylation on a nonhistone protein and suggest that aberrant lysine methylation of PCNA may play a role in human carcinogenesis. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22556262     DOI: 10.1158/0008-5472.CAN-11-3701

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  85 in total

1.  Histone H4K20 tri-methylation at late-firing origins ensures timely heterochromatin replication.

Authors:  Julien Brustel; Nina Kirstein; Fanny Izard; Charlotte Grimaud; Paulina Prorok; Christelle Cayrou; Gunnar Schotta; Alhassan F Abdelsamie; Jérôme Déjardin; Marcel Méchali; Giuseppe Baldacci; Claude Sardet; Jean-Charles Cadoret; Aloys Schepers; Eric Julien
Journal:  EMBO J       Date:  2017-08-04       Impact factor: 11.598

Review 2.  SET for life: biochemical activities and biological functions of SET domain-containing proteins.

Authors:  Hans-Martin Herz; Alexander Garruss; Ali Shilatifard
Journal:  Trends Biochem Sci       Date:  2013-10-20       Impact factor: 13.807

3.  A dual role for the histone methyltransferase PR-SET7/SETD8 and histone H4 lysine 20 monomethylation in the local regulation of RNA polymerase II pausing.

Authors:  Priya Kapoor-Vazirani; Paula M Vertino
Journal:  J Biol Chem       Date:  2014-01-23       Impact factor: 5.157

4.  Histone methyltransferase Setd8 represses Gata2 expression and regulates erythroid maturation.

Authors:  Jeffrey Malik; Michael Getman; Laurie A Steiner
Journal:  Mol Cell Biol       Date:  2015-04-06       Impact factor: 4.272

Review 5.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

6.  Turning a Substrate Peptide into a Potent Inhibitor for the Histone Methyltransferase SETD8.

Authors:  Russell A Judge; Haizhong Zhu; Anup K Upadhyay; Pierre M Bodelle; Charles W Hutchins; Maricel Torrent; Violeta L Marin; Wenyu Yu; Masoud Vedadi; Fengling Li; Peter J Brown; William N Pappano; Chaohong Sun; Andrew M Petros
Journal:  ACS Med Chem Lett       Date:  2016-10-11       Impact factor: 4.345

7.  Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma.

Authors:  Veronica Veschi; Zhihui Liu; Ty C Voss; Laurent Ozbun; Berkley Gryder; Chunhua Yan; Ying Hu; Anqi Ma; Jian Jin; Sharlyn J Mazur; Norris Lam; Barbara K Souza; Giuseppe Giannini; Gordon L Hager; Cheryl H Arrowsmith; Javed Khan; Ettore Appella; Carol J Thiele
Journal:  Cancer Cell       Date:  2017-01-09       Impact factor: 31.743

8.  Association of functional polymorphism at the miR-502-binding site in the 3' untranslated region of the SETD8 gene with risk of childhood acute lymphoblastic leukemia, a preliminary report.

Authors:  Mohammad Hashemi; Maryam Sheybani-Nasab; Majid Naderi; Fatemeh Roodbari; Mohsen Taheri
Journal:  Tumour Biol       Date:  2014-07-23

Review 9.  Clinically Applicable Inhibitors Impacting Genome Stability.

Authors:  Anu Prakash; Juan F Garcia-Moreno; James A L Brown; Emer Bourke
Journal:  Molecules       Date:  2018-05-13       Impact factor: 4.411

10.  Design, synthesis, and protein methyltransferase activity of a unique set of constrained amine containing compounds.

Authors:  Hao Zhou; Xin Che; Guochen Bao; Na Wang; Li Peng; Kimberly D Barnash; Stephen V Frye; Lindsey I James; Xu Bai
Journal:  Bioorg Med Chem Lett       Date:  2016-08-03       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.